# FDA recall D-0303-2020

> **Sato Pharmaceutical Inc.** · Class III · drug recall initiated 2019-10-01.

## Product

Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA  90501; NDC 49873-404-01.

## Reason for recall

Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.

## Distribution

Nationwide in the USA and Guam and Saipan, Northern Mariana Islands

## Key facts

- **Recall number:** D-0303-2020
- **Recalling firm:** Sato Pharmaceutical Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-10-01
- **Report date:** 2019-11-13
- **Termination date:** 2020-08-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Torrance, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0303-2020

## Citation

> AI Analytics. FDA recall D-0303-2020. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-0303-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*